N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
US10611758B2 · kind B2 · utility
4Cited by
9References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2019 |
| Grant date | Apr 7, 2020 |
| Priority date | — |
| Expiry date | Jul 2, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R5, R6, R7, A, B, W, X, Y and Z are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.